BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Q, Gao X, Yuan Z, Wang Z, Meng Y, Cao Y, Plotnikoff NP, Griffin N, Shan F. Methionine enkephalin (MENK) improves lymphocyte subpopulations in human peripheral blood of 50 cancer patients by inhibiting regulatory T cells (Tregs). Hum Vaccin Immunother 2014;10:1836-40. [PMID: 25424790 DOI: 10.4161/hv.28804] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Wang R, Zhang Y, Shan F. Interaction of opioid growth factor (OGF) and opioid antagonist and their significance in cancer therapy. International Immunopharmacology 2019;75:105785. [DOI: 10.1016/j.intimp.2019.105785] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
2 Mclaughlin PJ, Zagon IS. Duration of opioid receptor blockade determines biotherapeutic response. Biochemical Pharmacology 2015;97:236-46. [DOI: 10.1016/j.bcp.2015.06.016] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
3 Geng J, Yuan Y, Jiao X, Wang R, Liu N, Chen H, Griffin N, Shan F. Novel modulation on myeloid-derived suppressor cells (MDSCs) by methionine encephalin (MENK). Int Immunopharmacol 2019;68:193-203. [PMID: 30654309 DOI: 10.1016/j.intimp.2019.01.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
4 Bodnar RJ. Endogenous opiates and behavior: 2014. Peptides 2016;75:18-70. [PMID: 26551874 DOI: 10.1016/j.peptides.2015.10.009] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 7.6] [Reference Citation Analysis]
5 Li Z, You Y, Griffin N, Feng J, Shan F. Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy. International Immunopharmacology 2018;61:178-84. [DOI: 10.1016/j.intimp.2018.05.020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
6 Qu N, Wang R, Meng Y, Liu N, Zhai J, Shan F. Methionine enkephalin inhibited cervical carcinoma via apoptosis promotion and reduction of myeloid derived suppressor cell infiltrated in tumor. Int Immunopharmacol 2022;110:108933. [PMID: 35738090 DOI: 10.1016/j.intimp.2022.108933] [Reference Citation Analysis]
7 Chen BJ, Zhao JW, Zhang DH, Zheng AH, Wu GQ. Immunotherapy of Cancer by Targeting Regulatory T cells. Int Immunopharmacol 2022;104:108469. [PMID: 35008005 DOI: 10.1016/j.intimp.2021.108469] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Cui J, Song W, Jin Y, Xu H, Fan K, Lin D, Hao Z, Lin J. Research Progress on the Mechanism of the Acupuncture Regulating Neuro-Endocrine-Immune Network System. Vet Sci 2021;8:149. [PMID: 34437474 DOI: 10.3390/vetsci8080149] [Reference Citation Analysis]
9 Zagon IS, McLaughlin PJ. Intermittent blockade of OGFr and treatment of autoimmune disorders. Exp Biol Med (Maywood) 2018;243:1323-30. [PMID: 30541348 DOI: 10.1177/1535370218817746] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
10 Qu N, Meng Y, Handley MK, Wang C, Shan F. Preclinical and clinical studies into the bioactivity of low-dose naltrexone (LDN) for oncotherapy. Int Immunopharmacol 2021;96:107714. [PMID: 33989971 DOI: 10.1016/j.intimp.2021.107714] [Reference Citation Analysis]
11 Wang X, Tian J, Jiao X, Geng J, Wang R, Liu N, Gao X, Griffin N, Gao Y, Shan F. The novel mechanism of anticancer effect on gastric cancer through inducing G0/G1 cell cycle arrest and caspase-dependent apoptosis in vitro and in vivo by methionine enkephalin. Cancer Manag Res 2018;10:4773-87. [PMID: 30425572 DOI: 10.2147/CMAR.S178343] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
12 Wang DM, Jiao X, Plotnikoff NP, Griffin N, Qi RQ, Gao XH, Shan FP. Killing effect of methionine enkephalin on melanoma in vivo and in vitro. Oncol Rep 2017;38:2132-40. [PMID: 28849104 DOI: 10.3892/or.2017.5918] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
13 Zhao D, Plotnikoff N, Griffin N, Song T, Shan F. Methionine enkephalin, its role in immunoregulation and cancer therapy. International Immunopharmacology 2016;37:59-64. [DOI: 10.1016/j.intimp.2016.02.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
14 Li X, Meng Y, Plotnikoff NP, Youkilis G, Griffin N, Wang E, Lu C, Shan F. Methionine enkephalin (MENK) inhibits tumor growth through regulating CD4+Foxp3+ regulatory T cells (Tregs) in mice. Cancer Biol Ther 2015;16:450-9. [PMID: 25701137 DOI: 10.1080/15384047.2014.1003006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
15 Zhang J, Chen X, Wang J, Zhang P, Han X, Zhang Y, Wang Y, Yang X. Bioinformatics Analysis of Prognostic Value of SPC24 in ccRCC and Pan-Cancer. IJGM 2022;Volume 15:817-36. [DOI: 10.2147/ijgm.s348859] [Reference Citation Analysis]
16 Zhang S, Huang H, Handley M, Griffin N, Bai X, Shan F. A novel mechanism of lung cancer inhibition by methionine enkephalin through remodeling the immune status of the tumor microenvironment. Int Immunopharmacol 2021;99:107999. [PMID: 34315116 DOI: 10.1016/j.intimp.2021.107999] [Reference Citation Analysis]
17 Tian J, Jiao X, Wang X, Geng J, Wang R, Liu N, Gao X, Griffin N, Shan F. Novel effect of methionine enkephalin against influenza A virus infection through inhibiting TLR7-MyD88-TRAF6-NF-κB p65 signaling pathway. International Immunopharmacology 2018;55:38-48. [DOI: 10.1016/j.intimp.2017.12.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
18 Duque-Díaz E, Alvarez-Ojeda O, Coveñas R. Enkephalins and ACTH in the mammalian nervous system. Vitam Horm 2019;111:147-93. [PMID: 31421699 DOI: 10.1016/bs.vh.2019.05.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
19 Xu X, Gao Y, Wen L, Zhai Z, Zhang S, Shan F, Feng J. Methionine enkephalin regulates microglia polarization and function. International Immunopharmacology 2016;40:90-7. [DOI: 10.1016/j.intimp.2016.08.037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
20 Qu N, Wang X, Meng Y, Shan F. Prospective oncotarget for gynecological cancer: Opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis. Int Immunopharmacol 2019;75:105723. [PMID: 31408839 DOI: 10.1016/j.intimp.2019.105723] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Wang X, Jiao X, Meng Y, Chen H, Griffin N, Gao X, Shan F. Methionine enkephalin (MENK) inhibits human gastric cancer through regulating tumor associated macrophages (TAMs) and PI3K/AKT/mTOR signaling pathway inside cancer cells. Int Immunopharmacol 2018;65:312-22. [PMID: 30343258 DOI: 10.1016/j.intimp.2018.10.023] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]